PDD 00017273
Chemical Name: 1-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide
Purity: ≥98%
Biological Activity
PDD 00017273 is a potent and selective poly (ADP ribose) glycohydrolase (PARG) inhibitor (IC50 = 26 nM). Exhibits >350-fold selectivity for PARG over a panel of ion channels, enzymes and receptors, including PARP1 and ARH3. Maintains PAR chains and induces DNA double-stranded breaks in cells following DNA damage. Decreases colony formation of ZR-75-1 BRCA1 WT cells and inhibits cancer cell survival. Cell permeable.External Portal Information
Chemicalprobes.org is a portal that offers independent guidance on the selection and/or application of small molecules for research. The use of PDD 00017273 is reviewed on the chemical probes website.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
The CHD6 chromatin remodeler is an oxidative DNA damage response factor
S Moore, ND Berger, MS Luijsterbu, CG Piett, FKT Stanley, CU Schräder, S Fang, JA Chan, DC Schriemer, ZD Nagel, H van Attiku, AA Goodarzi
Nat Commun, 2019;10(1):241. -
First-in-class chemical probes against poly(ADP-ribose) glycohydrolase (PARG) inhibit DNA repair with differential pharmacology to Olaparib.
James et al.
ACS Chem.Biol., 2016;11:3179 -
Specific killing of DNA damage-response deficient cells with inhibitor of poly(ADP-ribose) glycohydrolase.
Gravells et al.
DNA Repair, 2017;52:81 -
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.
Houl et al.
Nat.Commun., 2019;10:5654 -
Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
H Zuo, D Yang, Q Yang, H Tang, YX Fu, Y Wan
Nat Commun, 2020;11(1):1578.
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for PDD 00017273
The citations listed below are publications that use Tocris products. Selected citations for PDD 00017273 include:
18 Citations: Showing 1 - 10
-
Poly ADP-ribosylation of SET8 leads to aberrant H4K20 methylation in mammalian nuclear genome.
Authors: Pierre-Olivier Et al.
Commun Biol 2022;5:1292
-
MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression.
Authors: Matthias Et al.
Cell Rep 2022;39:110879
-
PARP inhibition impedes the maturation of nascent DNA strands during DNA replication.
Authors: Margarita Et al.
Nat Struct Mol Biol 2022;29:329-338
-
CARM1 regulates replication fork speed and stress response by stimulating PARP1.
Authors: Mark T Et al.
Mol Cell 2021;81:784-800.e8
-
Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps.
Authors: Jiri Et al.
Mol Cell 2021;81:4692-4708.e9
-
XRCC1 prevents toxic PARP1 trapping during DNA base excision repair.
Authors: Keith W Et al.
Mol Cell 2021;81:3018-3030.e5
-
CDKL5 kinase controls transcription-coupled responses to DNA damage.
Authors: Rachel Et al.
EMBO J 2021;40:e108271
-
NAD+ bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cells.
Authors: Mai Et al.
NAR Cancer 2021;3:zcab044
-
Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents.
Authors: Amber Et al.
Front Oncol 2021;11:745981
-
Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair.
Authors: Keith W Et al.
Nucleic Acids Res 2020;48:6672-6684
-
The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency.
Authors: Marco Et al.
Cell Rep 2020;32:107985
-
Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer.
Authors: Yanyuan Et al.
Cancers (Basel) 2020;12
-
Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma.
Authors: Jian Et al.
Theranostics 2020;10:6530-6543
-
ELTA: Enzymatic Labeling of Terminal ADP-Ribose.
Authors: Yoshinari Et al.
Mol Cell 2019;73:845-856.e5
-
Unanchored tri-NEDD8 inhibits PARP-1 to protect from oxidative stress-induced cell death.
Authors: Keuss Et al.
EMBO J 2019;38
-
Selective Small Molecule PARG Inhibitor Causes Replication Fork Stalling and Cancer Cell Death.
Authors: Houl Et al.
Nat Commun 2019;10:5654
-
The CHD6 chromatin remodeler is an oxidative DNA damage response factor.
Authors: Moore Et al.
Nat Commun 2019;10:241
-
The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication.
Authors: Hanzlikova Et al.
Mol Cell 2018;71:319
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for PDD 00017273
There are currently no reviews for this product. Be the first to review PDD 00017273 and earn rewards!
Have you used PDD 00017273?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image